SoftBank Vision Fund L.P.'s Net Worth
$0
Estimate Recalculated Nov 1, 2024 06:31AM EST
Who is SoftBank Vision Fund L.P.?
SoftBank Vision Fund L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Urovant Sciences Ltd., Axovant Sciences Ltd., and Getaround, Inc.
SEC CIK
SoftBank Vision Fund L.P.'s CIK is 0001699940
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Myovant Sciences Ltd. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Roivant Sciences Ltd. (ROIV) Snapshot price: $12.4
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.04% | -10.00M |
$12.60 | -$126,000,000.00 | 73.03M |
Sep 28
| |||
Form 4
| -12.63% | -12.00M |
$8.00 | -$96,000,000.00 | 83.03M |
Mar 20
| |||
Form 4
| -4.37% | -4.34M |
$4.75 | -$20,633,615.25 | 95.03M |
Nov 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Urovant Sciences Ltd. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.08% | 18.2K |
$8.32 | $151,380.99 | 22.86M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.10% | 22.01K |
$8.06 | $177,300.64 | 22.84M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.09% | 21.34K |
$8.31 | $177,247.38 | 22.82M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.09% | 21.12K |
$7.86 | $165,950.15 | 22.8M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.08% | 17.75K |
$7.83 | $138,946.36 | 22.78M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.02% | 14.48K |
$7.64 | $110,461.18 | 68.24M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.09% | 19.83K |
$8.22 | $162,918.35 | 22.75M |
Scheduled
|
May 21 - May 23
| ||
Form 4
| +0.10% | 21.61K |
$7.54 | $162,875.90 | 22.73M |
May 16 - May 20
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.45
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.71% | 6.67M |
$1.50 | $10,000,000.50 | 105.95M |
Mar 18
| |||
Form 4
| +11.20% | 10M |
$1.00 | $10,000,000.00 | 99.29M |
Dec 18
| |||
Form 4
| +19.05% | 14.29M |
$1.75 | $24,999,999.50 | 89.29M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |